Cryoglobulinemia: Clinical Trials

10 trials for Cryoglobulinemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 3 unknown, 2 recruiting, 1 terminated. 5 Phase 2, 1 Phase 1, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Terminated 1, Unknown 1
Phase 11Completed 1
Phase 31Completed 1

Follow Cryoglobulinemia: new trials by email Literature Review of Cryoglobulinemia trials Research Report on Cryoglobulinemia

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Belimumab in the Treatment of Non-infectious Active Cryoglobulinemia Vasculitis Compared to Placebo. TRIBECA STUDY (Treatment nd BElimumab in Cryoglobulinemia Associated Vasculitis)
Belimumab, Placebo - Vasculitis, Cryoglobulinemia
Phase 2UnknownAssistance Publique - Hôpitaux de Paris482021-10-202024-06-26
A Cohort Study of Plasma Cell Disorders (PCDs) in PKUFH
No intervention - Multiple Myeloma, Amyloidosis
RecruitingPeking University First Hospital20002021-07-012026-09-16
Registry for Adults With Plasma Cell Disorders (PCD's)
Multiple Myeloma, Amyloidosis
RecruitingUNC Lineberger Comprehensive Cancer Center20002018-02-092025-11-20
Long-term Outcomes of Chronic Hepatitis C Patients Post Sofosbuvir-based Treatment
Observation only - Liver Fibroses, HepatoCellular Carcinoma
UnknownKaohsiung Medical University Chung-Ho Memorial Hospital2002016-08-012021-10-12
Efficacy of All-Oral Anti-Viral Therapy for Symptomatic Hepatitis C Virus Infection-Related Cryoglobulinemia
Harvoni, Epclusa - Hepatitis C, Cryoglobulinemia
Phase 2 / Phase 3CompletedIcahn School of Medicine at Mount Sinai102016-02-012020-12-17
Rituximab Plus Corticosteroids in Non-infectious Active Mixed Cryoglobulinemia Vasculitis
rituximab, Prednisone, Placebo - Cryoglobulinemia, Systemic Vasculitis
Phase 2TerminatedAssistance Publique - Hôpitaux de Paris142015-07-172019-03-18
Direct Antiviral Agents for Hepatitis C Virus-associated Cryoglobulinaemia Vasculitis
new antiviral therapy - Vasculitis, Cryoglobulinemia
UnknownAssistance Publique - Hôpitaux de Paris1202013-11-012016-09-29
The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders
Rituximab (MABTHERA® or RITUXAN®). - Pemphigus, Auto-immune Thrombocytopenic Purpura
CompletedUniversity Hospital, Toulouse352009-06-012012-10-23
Evaluation of Clinical Efficacy and Immunologic Response After IL-2 Therapy in HCV-related Vasculitis Patients
Proleukin - Cryoglobulinemia Vasculitis
Phase 1 / Phase 2CompletedFrench National Agency for Research on AIDS and Viral Hepatitis102008-03-012026-04-06
Rituximab to Treat Hepatitis C-Associated Cryoglobulinemic Vasculitis
Rituximab - Hepatitis C, Vasculitis
Phase 2CompletedNational Institute of Allergy and Infectious Diseases (NIAID)472001-12-012012-04-16

Narrower conditions

Vasculitis (4)  ·  Hepatitis C (3)  ·  Amyloidosis (2)  ·  Castleman Disease (2)  ·  Leukemia, Plasma Cell (2)  ·  Multiple Myeloma (2)  ·  POEMS Syndrome (2)  ·  Smoldering Multiple Myeloma (2)  ·  Anemia, Hemolytic, Autoimmune (1)  ·  Carcinoma, Hepatocellular (1)  ·  Cryoglobulinemia, Familial Mixed (1)  ·  Cytopenia (1)  ·  Diabetes Mellitus (1)  ·  Hepatitis (1)

Broader conditions

Blood Protein Disorders (10)  ·  Cardiovascular Diseases (10)  ·  Hematologic Diseases (10)  ·  Hemic and Lymphatic Diseases (10)  ·  Hemorrhagic Disorders (10)  ·  Hemostatic Disorders (10)  ·  Immune System Diseases (10)  ·  Immunoproliferative Disorders (10)  ·  Paraproteinemias (10)  ·  Skin Diseases (10)  ·  Skin Diseases, Vascular (10)  ·  Skin and Connective Tissue Diseases (10)  ·  Vascular Diseases (10)  ·  Digestive System Diseases (4)  ·  Liver Diseases (4)

Interventions

Rituximab (3)  ·  Prednisone (1)  ·  aldesleukin (1)  ·  belimumab (1)  ·  ledipasvir, sofosbuvir drug combination (1)  ·  sofosbuvir-velpatasvir drug combination (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (3)  ·  French National Agency for Research on AIDS and Viral Hepatitis (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Kaohsiung Medical University Chung-Ho Memorial Hospital (1)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (1)  ·  Peking University First Hospital (1)  ·  UNC Lineberger Comprehensive Cancer Center (1)  ·  University Hospital, Toulouse (1)

Countries

France (5)  ·  United States (3)  ·  China (1)  ·  South Korea (1)  ·  Taiwan (1)

Top investigators

Chia-Yen Dai (1)  ·  Ching-I Huang (1)  ·  Chung-Feng Huang (1)  ·  Jee-Fu Huang (1)  ·  Laurent Sailler (1)  ·  Michael C Sneller, MD (1)  ·  Ming-Lun Yeh (1)  ·  Ming-Lung Yu (1)  ·  Patrice Cacoub, MD, PHD (1)  ·  Peter Gorevic, MD (1)  ·  Sascha Tuchman, MD (1)  ·  Ta-Wei Liu (1)

Results publications

PMID 22129253, PMID 22147444, PMID 40205145